Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Zenalux Partners with Tulane UniversityZenalux and Tulane collaborate to monitor tumor response to investigational cancer therapy
By: Zenalux, Tulane Damir Khismatullin, Associate Professor of Biomedical Engineering at Tulane University, commented: “We have used the Zenascope to monitor tumor response to an investigational cancer therapy. The ability of the system to provide rapid feedback and its ease-of-use have allowed us to track tissue oxygenation in individual animals over time, and has provided another set of useful endpoints for our work.” This work was presented at the World Congress of Endourology in October. Researchers at the Tulane University School of Medicine are also deploying the Zenascope system to monitor histological and physiological changes in wounded tissues in response to investigational regenerative therapies. “We are thrilled to be collaborating with yet another prestigious institution through our Research Partnership Program,” said Dr. Jesko von Windheim, CEO of Zenalux. “We are very pleased that this research partnership provides us with additional application paths for the Zenascope, and we look forward to detailing the findings of the studies in the near future.” The Zenascope PC1, an ultraviolet- The specialized, real-time, diagnostic device shines white light on opaque target media, and then measures and analyzes the reflected signal. The system achieves rapid, quantitative, and non-destructive analysis of the following biological endpoints: oxy-hemoglobin concentration ([HBO2]); deoxy-hemoglobin concentration ([HHb]); total hemoglobin concentration (THC); blood saturation (SO2); and scatterer size and density. Additional applications for the Zenascope™ system include accelerating feedback in drug discovery; breast tumor margin assessment; assessment of response to cancer therapy; and screening and diagnostic applications in breast, cervical, and head and neck cancer. Zenascope is currently designated for investigational purposes only. Interested organizations can contact Zenalux at info@zenalux.com or 919-794-5757 x504. About Zenalux Biomedical, Inc. Zenalux Biomedical is a biomedical diagnostics start-up company that is developing novel biophotonic- Keywords: Zenalux, Tulane University, Zenascope™, PC1, biomedical, biophotonics, pre-clinical, in vivo, ex vivo, renal ischemia, cancer, research End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|